Glimepiride Industry Sees Continued Growth with Increasing Demand for Diabetes Management Solutions https://dataintelo.com/report/glimepiride-industry The Glimepiride Industry is poised for sustained growth as the global demand for diabetes management solutions continues to rise. According to Dataintelo's latest report, the market was valued at USD 5.8 billion in 2023 and is projected to reach USD 9.4 billion by 2032, expanding at a CAGR of 5.5% during the forecast period. Glimepiride, a second-generation sulfonylurea medication, is primarily used in the treatment of type 2 diabetes. As the prevalence of diabetes worldwide continues to rise, the demand for effective and affordable treatments like Glimepiride is expected to grow.